CD160 Expression in Retinal Vessels is Associated With Retinal Neovascular Diseases
Clinical trial NCT03940664 · COMPLETED
Trial details
- NCT number
- NCT03940664
- Sponsor
- CHU de Reims
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2008-01-01
- Primary completion
- 2017-01-01
- Enrollment
- 75
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.